Related Experiment Videos
Circadian changes in the elimination of misonidazole in mouse
Research Communications in Chemical Pathology and Pharmacology
|November 1, 1983
Abstract:
Intraperitoneal doses of Misonidazole were administered at 15.00 hours and 03.00 hours to Balb c/cenlco mice standardized in controlled environmental cages for 3 weeks before the experiment. Non linear pharmacokinetic and temporal variations in the apparent half life were obtained at higher doses.
Insights
Misonidazole pharmacokinetics were studied in mice. Higher doses showed non-linear drug behavior and changing half-life over time.
Area of Science:
- Pharmacology
- Pharmacokinetics
- Drug Metabolism
Background:
- Misonidazole is a hypoxia-activated prodrug used in cancer research.
- Understanding its pharmacokinetic profile is crucial for effective therapeutic strategies.
- Temporal variations in drug half-life can impact treatment efficacy.
Purpose of the Study:
- To investigate the pharmacokinetic profile of Misonidazole in Balb c/cenlco mice.
- To determine if Misonidazole exhibits dose-dependent pharmacokinetic behavior.
- To analyze temporal variations in the apparent half-life of Misonidazole.
Main Methods:
- Intraperitoneal administration of Misonidazole to standardized Balb c/cenlco mice.
- Dosing occurred at two specific time points: 15:00 and 03:00 hours.
- Mice were housed in controlled environmental cages for 3 weeks prior to experimentation.
Main Results:
- Non-linear pharmacokinetic behavior was observed at higher doses of Misonidazole.
- Significant temporal variations in the apparent half-life of Misonidazole were detected.
- The drug's elimination rate appears to be dose-dependent.
Conclusions:
- Misonidazole pharmacokinetics are complex and dose-dependent.
- The apparent half-life of Misonidazole is not constant and varies over time.
- These findings highlight the importance of considering dosing schedules and drug concentrations in Misonidazole therapy.